Home / Program / Main Program / Symposium 27
Symposium 27:Rapid Molecular Diagnosis and Detection of Drug Resistance of TB: Critical Tools to Achieve the Goal of Ending TB

The World Health Organization (WHO) has recommended the use of rapid molecular tests as the initial diagnostic test in patients suspected to have tuberculosis (TB). The significant advances of molecular assays in detecting TB and performing drug susceptibility testing may play a critical role in achieving the goal of ending TB by 2030. This symposium will cover an overview of the most recent advances of molecular technology in diagnosis of TB, in detection of resistance to conventional and new anti-TB medications.

Date: Monday, April 29, 2023 | Time: 09:00-10:30 (GMT+8)
Topic Speaker Country / Region
09:00-09:30 Recent advances in rapid molecular diagnosis of tuberculosis TBD TBD
09:30-10:00 Diagnosis of bedaquiline, delamanid, and pretomanid resistance Prof. Sushil Pandey Australia
10:00-10:30 Molecular drug resistance assays of new anti-tuberculosis medications – bedaquiline, delamanid, and pretomanid. TBD TBD